Homoharringtonine

Botanicalexperimental

Clinical trial activity

4 trials · 11 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
4
Phase 3
1
Phase 4
0

Earliest trial started Mar 31, 2021 (NCT04824924)

Timeline

2020s

  1. Jan 1, 2021

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2022

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06394011Phase 2Feb 15, 2024Soochow University
NCT05457361Phase 3Mar 1, 2022China Medical University, First People's Hospital of Chenzhou, Hacettepe University, Peking University, Qingdao University, Southern Medical University, Sun Yat-Sen University, Xiamen University
NCT05513131Phase 2Sep 30, 2021Nanjing Medical University
NCT04824924Phase 2Mar 31, 2021Jiao Tong University
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (11)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
China Medical UniversityAcademic/Hospital1012022
First People's Hospital of ChenzhouAcademic/Hospital1012022
Hacettepe UniversityAcademic/Hospital1012022
Jiao Tong UniversityAcademic/Hospital1112021
Nanjing Medical UniversityAcademic/Hospital1112021
Peking UniversityAcademic/Hospital1012022
Qingdao UniversityAcademic/Hospital1012022
Soochow UniversityAcademic/Hospital1112024
Southern Medical UniversityAcademic/Hospital1112022
Sun Yat-Sen UniversityAcademic/Hospital1012022
Xiamen UniversityAcademic/Hospital1012022
11 organizations
Page 1 / 1